221 related articles for article (PubMed ID: 18989368)
1. PPARdelta Agonism for the Treatment of Obesity and Associated Disorders: Challenges and Opportunities.
Perreault M; Erbe DV; Tobin JF
PPAR Res; 2008; 2008():125387. PubMed ID: 18989368
[TBL] [Abstract][Full Text] [Related]
2. Advances and Challenges in Drug Design of PPARδ Ligands.
Maltarollo VG; Kronenberger T; Windshugel B; Wrenger C; Trossini GHG; Honorio KM
Curr Drug Targets; 2018; 19(2):144-154. PubMed ID: 28413978
[TBL] [Abstract][Full Text] [Related]
3. Cow's milk increases the activities of human nuclear receptors peroxisome proliferator-activated receptors alpha and delta and retinoid X receptor alpha involved in the regulation of energy homeostasis, obesity, and inflammation.
Suhara W; Koide H; Okuzawa T; Hayashi D; Hashimoto T; Kojo H
J Dairy Sci; 2009 Sep; 92(9):4180-7. PubMed ID: 19700678
[TBL] [Abstract][Full Text] [Related]
4. Association of peroxisome proliferator-activated receptor delta +294T/C with body mass index and interaction with peroxisome proliferator-activated receptor alpha L162V.
Aberle J; Hopfer I; Beil FU; Seedorf U
Int J Obes (Lond); 2006 Dec; 30(12):1709-13. PubMed ID: 16652134
[TBL] [Abstract][Full Text] [Related]
5. Structure-based virtual screening and discovery of New PPARδ/γ dual agonist and PPARδ and γ agonists.
Maltarollo VG; Togashi M; Nascimento AS; Honorio KM
PLoS One; 2015; 10(3):e0118790. PubMed ID: 25767888
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
7. Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5' adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor δ pathway.
Cheang WS; Tian XY; Wong WT; Lau CW; Lee SS; Chen ZY; Yao X; Wang N; Huang Y
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):830-6. PubMed ID: 24482374
[TBL] [Abstract][Full Text] [Related]
8. Novel approach to treat insulin resistance, type 2 diabetes, and the metabolic syndrome: simultaneous activation of PPARalpha, PPARgamma, and PPARdelta.
Evans JL; Lin JJ; Goldfine ID
Curr Diabetes Rev; 2005 Aug; 1(3):299-307. PubMed ID: 18220606
[TBL] [Abstract][Full Text] [Related]
9. Suppression of plasma free fatty acids upregulates peroxisome proliferator-activated receptor (PPAR) alpha and delta and PPAR coactivator 1alpha in human skeletal muscle, but not lipid regulatory genes.
Watt MJ; Southgate RJ; Holmes AG; Febbraio MA
J Mol Endocrinol; 2004 Oct; 33(2):533-44. PubMed ID: 15525607
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and structure-activity relationship study of peroxisome proliferator-activated receptor (PPAR) delta-selective ligands.
Miyachi H
Curr Med Chem; 2007; 14(22):2335-43. PubMed ID: 17896982
[TBL] [Abstract][Full Text] [Related]
11. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor delta protects against obesity-related glomerulopathy through the P38 MAPK pathway.
Yan Z; Ni Y; Wang P; Chen J; He H; Sun J; Cao T; Chen J; Zhao Z; Luo Z; Chen L; Liu D; Zhu Z
Obesity (Silver Spring); 2013 Mar; 21(3):538-45. PubMed ID: 23592661
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptors as attractive antiobesity targets.
Zhang F; Lavan B; Gregoire FM
Drug News Perspect; 2004 Dec; 17(10):661-9. PubMed ID: 15696231
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic modulators of peroxisome proliferator-activated receptors (PPAR): a patent review (2008-present).
Lamers C; Schubert-Zsilavecz M; Merk D
Expert Opin Ther Pat; 2012 Jul; 22(7):803-41. PubMed ID: 22697317
[TBL] [Abstract][Full Text] [Related]
15. The roles of peroxisome proliferator-activated receptors in the metabolic syndrome.
Mansour M
Prog Mol Biol Transl Sci; 2014; 121():217-66. PubMed ID: 24373239
[TBL] [Abstract][Full Text] [Related]
16. PPAR modulators and PPAR pan agonists for metabolic diseases: the next generation of drugs targeting peroxisome proliferator-activated receptors?
Feldman PL; Lambert MH; Henke BR
Curr Top Med Chem; 2008; 8(9):728-49. PubMed ID: 18537685
[TBL] [Abstract][Full Text] [Related]
17. Enhanced pan-peroxisome proliferator-activated receptor gene and protein expression in adipose tissue of diet-induced obese mice treated with telmisartan.
Penna-de-Carvalho A; Graus-Nunes F; Rabelo-Andrade J; Mandarim-de-Lacerda CA; Souza-Mello V
Exp Physiol; 2014 Dec; 99(12):1663-78. PubMed ID: 25326526
[TBL] [Abstract][Full Text] [Related]
18. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome Proliferator-Activated Receptor-γ: Master Regulator of Adipogenesis and Obesity.
Shao X; Wang M; Wei X; Deng S; Fu N; Peng Q; Jiang Y; Ye L; Xie J; Lin Y
Curr Stem Cell Res Ther; 2016; 11(3):282-9. PubMed ID: 26018229
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.
Vidal-Puig AJ; Considine RV; Jimenez-Liñan M; Werman A; Pories WJ; Caro JF; Flier JS
J Clin Invest; 1997 May; 99(10):2416-22. PubMed ID: 9153284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]